Trial Profile
Acceptability of Long-Term Progestin-Only Contraception in Europe.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2013
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary) ; Etonogestrel
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 07 Feb 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2011 Planned End Date changed from 1 Jun 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.